This Program is dedicated to the identification of new active agents both for the treatment and prevention of cancer.
Studies are available for the treatment of various tumor types using novel and conventional agents.
The goal of the program is to understand the basis of the actions of the drugs being studied with a view to maximizing their activity and safety when they become available for general clinical use. A close association of laboratory and clinical studies assures this objective. Pharmacologic and biologic studies in association with the clinical trials seek to individualize the use of cancer therapy. Similar strategies are used for the identification and treatment of patients who may be at higher risk of developing cancer, based either on their own or their family history. New interventions are being studied for these patient populations.